Investigating Neurocognitive, Motor and Biological Effects of MindLenses Professional in Neurological Diseases (MindLensesN)
Stroke, Mild Cognitive Impairment
About this trial
This is an interventional treatment trial for Stroke focused on measuring prism adaptation, cognitive training, neurological patients, neuropsychology
Eligibility Criteria
Inclusion Criteria: diagnosis of: Mild Cognitive Impairment, and stroke preserved use of at least one hand, normal or corrected to normal vision Exclusion Criteria: history of psychiatric and/or concurrent neurological diseases inability to provide informed consent, impaired comprehension of oral instructions,
Sites / Locations
- IRCCS San Camillo HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Active Comparator
Experimental Group
Control Group -1
Control Group -2
The group will undergo 10 sessions (2 weeks) of a treatment combining prismatic adaptation (PA) and serious games (SG) for cognitive training, using the Mindlenses Professional device. In each session, firtsly we will perform the PA procedure, followed by approximately 30 minutes of SG. SG will be focused on attention, executive functions and language.
The group will undergo 10 sessions (2 weeks) of a treatment using the serious games (SG) for cognitive training provided by the Mindlenses Professional device. SG will be focused on attention, executive functions and language.
The group will perform 2 weeks of the standard cognitive training offered by IRCCS San Camillo Hospital.